Donald L. Patrick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Donald L. Patrick has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
Margaret Rothman
Johnson & Johnson Pharmaceutical Services, Raritan, New Jersey
6 shared publicationsTari D. Topolski
Department of Health Services School of Public Health University of Washington Seattle Washington USA
5 shared publications- Henrica C. W. de Vet
Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
4 shared publications - Jordi Alonso
Hospital del Mar Research Institute, Barcelona, Spain
4 shared publications - Lex M. Bouter
Amsterdam University Medical Centers
4 shared publications - Paul W. Stratford
School of Rehabilitation Science, McMaster University, Hamilton, Canada
4 shared publications
Latest Publications
- Open Access
- 8 October 2014
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 12 (1) , 147
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module
- 8 October 2014
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 12 (1) , 147
Open AccessDevelopment of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module
- 18 June 2014
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 38 (2) , 350-354
Multi-level Intervention to increase participation in mammography screening: ¡Fortaleza Latina! study design
- 18 June 2014
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 38 (2) , 350-354
Multi-level Intervention to increase participation in mammography screening: ¡Fortaleza Latina! study design
- 1 June 2013
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (6) , 836-845
Psychometric Performance of the Incontinence Quality-of-Life Questionnaire Among Patients With Overactive Bladder and Urinary Incontinence
- 1 June 2013
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (6) , 836-845
Psychometric Performance of the Incontinence Quality-of-Life Questionnaire Among Patients With Overactive Bladder and Urinary Incontinence
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1123 Development of the Ulcerative Colitis Patient-Reported Outcomes (UC-PRO) Questionnaire
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1123 Development of the Ulcerative Colitis Patient-Reported Outcomes (UC-PRO) Questionnaire
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1124 Development of the Crohn's Disease Patient-Reported Outcomes (CD-PRO) Questionnaire
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1124 Development of the Crohn's Disease Patient-Reported Outcomes (CD-PRO) Questionnaire
- Open Access
- 1 January 2013
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 211
Patient-reported outcomes in meta-analyses --Part 2: methods for improving interpretability for decision-makers
Systematic reviews and meta-analyses of randomized trials that include patient-reported outcomes (PROs) often provide crucial information for patients, clinicians and policy-makers facing challenging health care decisions. Based on emerging methods, guidance on improving the interpretability of meta-analysis of patient-reported outcomes, typically continuous in nature, is likely to enhance decision-making. The objective of this paper is to summarize approaches to enhancing the interpretability of pooled estimates of PROs in meta-analyses. When differences in PROs between groups are statistically significant, decision-makers must be able to interpret the magnitude of effect. This is challenging when, as is often the case, clinical trial investigators use different measurement instruments for the same construct within and between individual randomized trials. For such cases, in addition to pooling results as a standardized mean difference, we recommend that systematic review authors use other methods to present results such as relative (relative risk, odds ratio) or absolute (risk difference) dichotomized treatment effects, complimented by presentation in either: natural units (e.g. overall depression reduced by 2.4 points when measured on a 50-point Hamilton Rating Scale for Depression); minimal important difference units (e.g. where 1.0 unit represents the smallest difference in depression that patients, on average, perceive as important the depression score was 0.38 (95%CI 0.30 to 0.47) units less than the control group); or a ratio of means (e.g. where the mean in the treatment group is divided by the mean in the control group, the ratio of means is 1.27, representing a 27%relative reduction in the mean depression score).
- 1 January 2013
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 211
Open AccessPatient-reported outcomes in meta-analyses --Part 2: methods for improving interpretability for decision-makers
Systematic reviews and meta-analyses of randomized trials that include patient-reported outcomes (PROs) often provide crucial information for patients, clinicians and policy-makers facing challenging health care decisions. Based on emerging methods, guidance on improving the interpretability of meta-analysis of patient-reported outcomes, typically continuous in nature, is likely to enhance decision-making. The objective of this paper is to summarize approaches to enhancing the interpretability of pooled estimates of PROs in meta-analyses. When differences in PROs between groups are statistically significant, decision-makers must be able to interpret the magnitude of effect. This is challenging when, as is often the case, clinical trial investigators use different measurement instruments for the same construct within and between individual randomized trials. For such cases, in addition to pooling results as a standardized mean difference, we recommend that systematic review authors use other methods to present results such as relative (relative risk, odds ratio) or absolute (risk difference) dichotomized treatment effects, complimented by presentation in either: natural units (e.g. overall depression reduced by 2.4 points when measured on a 50-point Hamilton Rating Scale for Depression); minimal important difference units (e.g. where 1.0 unit represents the smallest difference in depression that patients, on average, perceive as important the depression score was 0.38 (95%CI 0.30 to 0.47) units less than the control group); or a ratio of means (e.g. where the mean in the treatment group is divided by the mean in the control group, the ratio of means is 1.27, representing a 27%relative reduction in the mean depression score).
- Open Access
- 1 January 2013
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 109
Patient-reported outcomes in meta-analyses – Part 1: assessing risk of bias and combining outcomes
Systematic reviews and meta-analyses of randomized trials that include patient-reported outcomes (PROs) often provide crucial information for patients and clinicians facing challenging health care decisions. Based on emerging methods, guidance on combining PROs in meta-analysis is likely to enhance their usefulness. The objectives of this paper are: i) to describe PROs and why they are important for health care decision-making, ii) illustrate the key risk of bias issues that systematic reviewers should consider and, iii) address outcome characteristics of PROs and provide guidance for combining outcomes. We suggest a step-by-step approach to addressing issues of PROs in meta-analyses. Systematic reviewers should begin by asking themselves if trials have addressed all the important effects of treatment on patients’ quality of life. If the trials have addressed PROs, have investigators chosen the appropriate instruments? In particular, does evidence suggest the PROs used are valid and responsive, and is the review free of outcome reporting bias? Systematic reviewers must then decide how to categorize PROs and when to pool results.
- 1 January 2013
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 109
Open AccessPatient-reported outcomes in meta-analyses – Part 1: assessing risk of bias and combining outcomes
Systematic reviews and meta-analyses of randomized trials that include patient-reported outcomes (PROs) often provide crucial information for patients and clinicians facing challenging health care decisions. Based on emerging methods, guidance on combining PROs in meta-analysis is likely to enhance their usefulness. The objectives of this paper are: i) to describe PROs and why they are important for health care decision-making, ii) illustrate the key risk of bias issues that systematic reviewers should consider and, iii) address outcome characteristics of PROs and provide guidance for combining outcomes. We suggest a step-by-step approach to addressing issues of PROs in meta-analyses. Systematic reviewers should begin by asking themselves if trials have addressed all the important effects of treatment on patients’ quality of life. If the trials have addressed PROs, have investigators chosen the appropriate instruments? In particular, does evidence suggest the PROs used are valid and responsive, and is the review free of outcome reporting bias? Systematic reviewers must then decide how to categorize PROs and when to pool results.
- Open Access
- 31 July 2012
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 88 (5) , 443-8
Youth Quality of Life Instrument-Research version (YQOL-R): psychometric proprieties in a community sample
To test some psychometric properties of the Brazilian-Portuguese version of the Youth Quality of Life Instrument-Research (YQOL-R) in a community sample of Brazilian adolescents. This is a cross-sectional community study conducted in six schools of the catchment area of a family health unit. From an original population of 2,754 students from 10 to 17 years old, we randomly selected 419 to answer the Brazilian-Portuguese version of the YQOL-R. We tested reliability, known group differences (using anxiety symptoms and bullying involvement), and factor structure. The YQOL-R showed a good internal consistency and had an adequate and expected known group differences with both bullying and anxiety. The factor structure of the conceptual model was partially supported by our analysis. The Brazilian-Portuguese version of the YQOL-R showed sufficiently good psychometric properties. Further studies are needed in order to better investigate alternative configurations of the factor structure.
- 31 July 2012
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 88 (5) , 443-8
Open AccessYouth Quality of Life Instrument-Research version (YQOL-R): psychometric proprieties in a community sample
To test some psychometric properties of the Brazilian-Portuguese version of the Youth Quality of Life Instrument-Research (YQOL-R) in a community sample of Brazilian adolescents. This is a cross-sectional community study conducted in six schools of the catchment area of a family health unit. From an original population of 2,754 students from 10 to 17 years old, we randomly selected 419 to answer the Brazilian-Portuguese version of the YQOL-R. We tested reliability, known group differences (using anxiety symptoms and bullying involvement), and factor structure. The YQOL-R showed a good internal consistency and had an adequate and expected known group differences with both bullying and anxiety. The factor structure of the conceptual model was partially supported by our analysis. The Brazilian-Portuguese version of the YQOL-R showed sufficiently good psychometric properties. Further studies are needed in order to better investigate alternative configurations of the factor structure.
- Open Access
- 1 January 2012
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 10 (1) , 125
Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
This study evaluated the measurement properties of a newly developed instrument – the Self-Management Profile for Type 2 Diabetes (SMP-T2D).
- 1 January 2012
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 10 (1) , 125
Open AccessDevelopment and validation of the self-management profile for type 2 diabetes (SMP-T2D)
This study evaluated the measurement properties of a newly developed instrument – the Self-Management Profile for Type 2 Diabetes (SMP-T2D).